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We established a method to generate integration from extrachromosomal arrays with the CRISPR/Cas9
system. Multi-copy transgenes were integrated into the deﬁned loci of chromosomes by this method,
while a multi-copy transgene is integrated into random loci by previous methods, such as UV- and
gamma-irradiation. The effects of a combination of sgRNAs, which deﬁne the cleavage sites in extra-
chromosomes and chromosomes, and the copy number of potential cleavable sequences were examined.
The relative copy number of cleavable sequences in extrachromosomes affects the frequency of fertile F1
transgenic animals. The expression levels of the reporter gene were almost proportional to the copy
numbers of the integrated sequences at the same integration site. The technique is applicable to the
transgenic strains abundantly stored and shared among the C. elegans community, particularly when
researchers use sgRNAs against common plasmid sequences such as β-lactamase.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
To perform molecular genetic analyses using a model organism,
techniques for generating transgenic animals are essential. In C.
elegans transgenic animals are often obtained using DNA micro-
injection into the hermaphrodite gonad, which generates multi-
copy extrachromosomal (Ex) arrays [1,2]. Extrachromosomal ar-
rays can then be integrated into random loci of chromosomes by
gamma-ray or ultraviolet irradiation [3,4], so that the integrated
arrays contain a high copy-number of transgenes. A technique
termed Mos1-mediated single-copy insertion (MosSCI) is often the
method of choice to insert a single-copy transgene into a deﬁned
location in the chromosomes of C. elegans [5,6]. Extrachromosomal
arrays can also be integrated into random loci of chromosomes by
using UV/TMP, benzimidazole and temperature selection [7,8]. In
these cases, integrated transgenes contain single/low-copy trans-
genes and are useful for genes with low expression levels. Re-
cently, the CRISPR/Cas9 system, which can induce double-strand
breaks at speciﬁc loci in genomic DNA using speciﬁc sgRNAs, has
been successfully applied to C. elegans [9]. The system has been
widely used to produce small indels [9]. In addition, the CRISPR/
Cas9 system allows homologous recombination-mediated inser-
tion of sequence tags such as GFP [10–12].B.V. This is an open access article u
gy, Tokyo Women's MedicalIn the present study, we developed a technique using the
CRISPR/Cas9 system to produce integrations from extra-
chromosomal arrays. This method allows the insertion of multi-
copy transgenes at desired loci in chromosomes. In addition, we
also demonstrate transgene integration of a relatively small
number of copies using the CRISPR/Cas9 system together with
benzimidazole and temperature selection.2. Materials and methods
2.1. Nematode strains
C. elegans strain N2 worms were used as the wild-type animals.
Worms were grown at 20 °C under well-fed conditions using the
standard methods [13]. Strains carrying the following mutations
were obtained from a UV/TMP-mutagenized library as described
previously [14] and identiﬁed by PCR ampliﬁcation with primers
spanning the deletion region of ben-1(tm234)III and vps-45(tm246)X,
as described previously [14,15]. The primers used for PCR genotyping
were as follows: tm234_1stround, 5′-ACGTGGGAATGGAACCATGT-3′,
5′-TCTCCATTTCCTCTTCCTCC-3′; tm234_2ndround, 5′-CTCCGGA-
CATTGTAACGGAA-3′, 5′-CCCTCCATTTGAAAGAGTCC-3′; tm246, 5′-
CGCAATTGGATACTACTTGT-3′, 5′-TCTCCTGCTCTACTTCTGCT-3′. The
mutants were backcrossed four times with N2 before use.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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We used site-directed mutagenesis to insert the guide sequences
into a Cas9-sgRNA (single guide RNA) expression vector (pDD162)
containing both sgRNA and Cas9 protein expression units, obtained
through Addgene [11]. dpy-3 was targeted for Cas9 cleavage using
the guide sequence (TCACCGTCCAGTCTGCTAC) inserted into
pDD162. ben-1 was targeted for Cas9 cleavage using the guide se-
quence (AAGCAACTGCAGAGGAAGA) inserted into pDD162. The β-
lactamase (ampicillin resistance) gene, which is contained in com-
monly used plasmids, was targeted for Cas9 cleavage using the
guide sequence (TTAATAGACTGGATGGAGG) inserted into pDD162.
We searched “CRISPR Design” (http://crispr.mit.edu) for potential
off-target sequences [16]. The guide sequence of dpy-3 had 1 can-
didate of off-target sites (0 are in genes, 4 mismatches (MMs), score
of off-target: 0.0). The guide sequence of ben-1 had 32 candidates of
off-target sites (0 are in genes, 4 of 3MMs and 28 of 4MMs, max
score of off-target: 1.5). The guide sequence of the β-lactamase gene
had 7 candidates of off-target sites (0 are in genes, 7 of 4MMs, max
score of off-target: 0.8). To generate a dpy-3 genome fragment
plasmid, pPD95.79_dpy-3, a part of the dpy-3 genome (491 bp), was
ampliﬁed by PCR using the primers 5′-CGACTCTAGAGGATCCGAA-
CAGTGAAGTAGACTTCTGCAAG-3′ and 5′- CGCTCAGTTGGAATTC-
CATCTTGTCCTGATGTACCGGCAT-3′ with the N2 genome as a tem-
plate. The fragment was inserted into the plasmid pPD95.79 using
the EcoRI and BamHI sites.
The plasmids for transgenic markers, myo-2p::Venus and dpy-
7p::DsRed, were generated as outlined previously [17]. The plas-
mids, pGEMT_ben-1(þ), pFX_HBG_Lw_dpy-30p::NLS::GFP and eft-
3p::vps-45 were constructed as described in a previous study [7].
2.3. Transgenic lines
Plasmids were injected using the standard C. elegans micro-
injection procedures [1]. To generate tmEx4252, tmEx4253 and
tmEx4277 transgenic animals, the pPD95.79_dpy-3 genome was
injected with myo-2p::Venus as an injection marker into N2
worms. The injection ratios of the mixed plasmids and the selec-
tion markers are listed in Table 1. We used the same tmEx3199 [eft-
3p::vps-45, pGEMT_ben-1(þ), pFX_HBG_Lw_dpy-30p::NLS::GFP]
transgenic animals that were used in a previous study [7]. Images
were taken with a BX-51 microscope (Olympus).
2.4. Generating integration lines using the CRISPR/Cas9 system
We injected Cas9-sgRNA plasmids with a selection marker, dpy-
7p::DsRed or myo-2p::DsRed, into the extrachromosomal trans-
genic animals. The target genes for the CRISPR/Cas9 system and
injected animals are listed in Table 1 and Supplementary Fig. 2B.
2.5. Quantitative PCR
Genomic DNA was isolated from adult animals using the
DNeasy Tissue & Blood kit (QIAGEN). Quantitative PCR was per-
formed in a 7500 Real-time Thermal cycler (Applied Biosystems)
using the Power SYBR master mix (Applied Biosystems) with the
following parameters: 95 °C for 10 min and 40 cycles of 95 °C for
5 s, 55 °C for 10 s and 72 °C for 34 s. All data were normalized to
the ama-1 gene. The primers used are listed in Supplementary
Table 1.
2.6. Isolation of integration lines using the CRISPR/Cas9 system and
the Dpy phenotype
Schematic diagram of the multi-copy integration is shown in
the Fig. 1. Ex line marker (Venus/GFP)-positive worms (P0) were
Fig. 1. Overview of multi-copy integration experiments by using the CRISPR/Cas9 system. An injection marker (myo-2p::Venus including β-lactamase gene) and a portion of
the dpy-3 genome sequence (optional) were co-injected into the N2 worms to generate transgenic strains carrying Ex arrays. Ex line marker (Venus)-positive worms (P0)
were injected with the Cas9-sgRNA plasmid(s), against the dpy-3 and/or β-lactamase gene(s), with an injection marker (dpy-7p::DsRed). Cas9-sgRNA plasmid(s) were de-
signed to break extrachromosomal arrays and the integration locus. Both the parent Ex marker- and injection marker-positive F1 worms were singled to new plates. The lines
that expressed Venus in all Dpy animals were selected as candidates for integrant (Is) strains. F2 Dpy worms in Is candidate strains were singled to new plates. Dpy worms
that had the parent Ex marker in all the F3 or later progeny were selected as Is lines.
S. Yoshina et al. / Biochemistry and Biophysics Reports 5 (2016) 70–7672injected with the Cas9-sgRNA plasmid(s), against the dpy-3 and/or
β-lactamase gene(s), with another injection marker, dpy-7p::DsRed
or myo-2p::DsRed. After a few days, both the parent Ex marker-
and injection marker-positive F1 worms were singled to new
plates. We selected the lines that expressed Venus/GFP in all Dpy
animals. The strains harboring inserted parental extra-
chromosomal arrays into the genomic location of the dpy-3 gene
were selected in this process. We selected Dpy worms as insertion
(Is) lines that had the parent Ex marker in all the F3 or later
progeny. We conﬁrmed that the Dpy phenotype did not segregate
with ﬂuorescence, and conﬁrmed that transgenes were integrated
at the dpy-3 gene by PCR and sequencing (Supplementary Fig. 1).
We performed PCR using puriﬁed genomic DNA of each Is strain as
a template. We designed primer sets located within the dpy-3
gene, which is not included in the extrachromosomal arrays, and
the vectors, which is included only in the extrachromosomal ar-
rays. The primers used in this experiment are listed in Supple-
mentary Table 2. High transmitting Ex lines were produced in this
experiment, but it was possible to exclude these Ex lines by our
method.
2.7. Isolation of integration lines using the CRISPR/Cas9 system with
the aid of benzimidazole, temperature and PCR selection
Schematic diagram of the integration is shown in the Supple-
mentary Fig. 2A. ben-1(tm234); vps-45(tm246); tmEx3199 [eft-3p::
vps-45, pGEMT_ben-1(þ), pFX_HBG_Lw_dpy-30p::NLS::GFP] (P0)
were injected with the Cas9-sgRNA plasmid, which targeted to the
ben-1 gene, and an injection marker, myo-2p::DsRed. After a few
days, both the parent Ex marker (dpy-30p::NLS::GFP)- and theinjection marker-positive F1 worms were singled to new plates
and incubated at 20 °C, while the F3 animals hatched. The F3 an-
imals were selected for integrant strains by benzimidazole and
temperature by using a modiﬁed version of a previously described
method [7,8]. Brieﬂy, F3 animals were plated onto NGM agar
plates containing 10 mg/ml benzimidazole (Wako) (approximately
50 animals/9-cm plate) and were cultured at 20 °C for 7–10 days.
F5 animals were plated onto NGM agar plates (approximately 100
animals/9-cm plate) and cultured at 20 °C for 3 days. In this pro-
cess, the integrant animals carrying the vps-45 transgene but not
carrying the complete ben-1 transgene were selected. Surviving
animals were singled and examined by PCR. The primers used are
listed in Supplementary Table 3. We conﬁrmed that the integra-
tion of transgenes at the ben-1 gene by PCR and sequencing
(Supplementary Fig. 1). We performed PCR using puriﬁed genomic
DNA of each Is strain as a template. We designed primer sets lo-
cated within the ben-1 gene, which is not included in the extra-
chromosomal arrays, and the vectors, which is included only in the
extrachromosomal arrays. The primers used in this experiment are
listed in Supplementary Table 2.3. Results and discussion
3.1. Transgene integration using the CRISPR/Cas9 system
We investigated whether the CRISPR/Cas9 system is able to
generate integrated transgenic worms, and how the number of
Cas9 cleavage sites in extrachromosomes affects the frequency of
isolation of transgenic animals. We ﬁrst attempted to determine
S. Yoshina et al. / Biochemistry and Biophysics Reports 5 (2016) 70–76 73whether a single sgRNA could cleave both extrachromosomal ar-
rays and the genomic target site by using an sgRNA targeting dpy-3
as the simplest experimental design (Fig. 1). Because dpy-3 mu-
tants show a highly penetrant visible and viable recessive phe-
notype termed “Dpy”, we inferred that integration of an extra-
chromosomal transgene into the dpy-3 locus would yield Dpy and
ﬂuorescence-positive integrant animals. Integrant Dpy lines can be
distinguished easily from parental extrachromosomal transgenic
animals without the Dpy phenotype. We selected Dpy worms as Is
lines that had the parent Ex marker (Venus) in all the F3 or later
progeny. To investigate the effect of the number of cleavage sites in
extrachromosomal array, we generated 3 parent Ex lines that ex-
pressed the myo-2p::Venus together with a portion of the dpy-3
genome sequence (491 bp) at three different concentration ratios
(Table 1, exp. 1–3). The dpy-3 genome fragment served as the
target for sgRNA against the dpy-3 locus, as shown in Fig. 1 and
Table 1.
We expressed Cas9, the dpy-3-speciﬁc sgRNA and a vector driving
the expression of dpy-7p::DsRed to label transformed F1 progeny from
the parent transgenic worms, tmEx4252, tmEx4277 or tmEx4253. We
isolated DsRed- and Venus-positive worms and screened their F2
progeny for Dpy phenotypes (Fig. 1). The integrated transgenic strains
in the progeny were easily identiﬁed by myo-2p::Venus ﬂuorescence
and Dpy (Table 1, column “No. producing Is”). We obtained integrant
strains at frequencies of 3.6%, 4.4% and 9.3% from tmEx4252, tmEx4277
and tmEx4253, respectively. Decreasing the number of dpy-3 sequence
in extrachromosomal arrays induced higher efﬁciency of generating
integrant strains (Supplementary Table 4, exp. 1–3). Notably, we ob-
tained F2 animals with the Dpy phenotype without Venus ﬂuores-
cence (Table 1, column “No. F1 producing Dpy F2”). This suggests that
not all of the animals with a double-strand break at the dpy-3 locus
accepted the extrachromosomal DNA fragments but were instead self-
repaired with some changes (small deletion and/or insertion) at the
locus, as found in many CRISPR/Cas9-induced knockout strains [9].
Candidates of integrated strains with Dpy and Venus-positive pheno-
types did not segregate Dpy and Venus negative nor non-Dpy and
Venus-positive in the present experiments. We conﬁrmed that the
transgenes were integrated at the dpy-3 locus by PCR and sequencing
(Supplementary Fig. 1). Thus, integration into off-target loci is rare if
not at all. Practically Venus ﬂuorescence alone is enough to isolate
integrated strains. We conclude that extrachromosomal arrays can be
integrated into chromosomal loci of interest by using the CRISPR/Cas9
system (Fig. 2). The frequencies of isolation of integrant strains were
between 3.6% and 9.3% of P0 strains, which is comparable to or a little
higher than the integration method by short wave-length UV irra-
diation, which yields integrant strains of up to 5% of P0 animals [3].
Our results suggest that a higher concentration of recognition se-
quences for sgRNAs in extrachromosomal arrays results in a lower
frequency of producing transgenic animals. To further examine this
hypothesis, we microinjected tmEx4252 transgenic worms with two
vectors encoding Cas9, dpy-3-, and β-lactamase-speciﬁc sgRNAs to-
gether with an injection marker, dpy-7p::DsRed. One integrant strain
was isolated from 40 injected P0 worms, suggesting that use of the β-
lactamase-speciﬁc sgRNA yielded integrated strains at a comparable or
slightly lower frequency (2.5%, Table 1, exp. 4) than that of injection of
the dpy-3 sgRNA alone (3.6%; Table 1, exp. 1). This result supports the
hypothesis that too many fragmented extrachromosomal arrays may
reduce the frequency of producing transgenic animals.
3.2. Homologous sequences in extrachromosomal arrays are dis-
pensable for generating integrant strains
There are abundant extrachromosomal transgenic strains
shared by the C. elegans research community stored in the CGC
(Caenorhabditis Genetics Center; http://www.cbs.umn.edu/re
search/resources/cgc/strains) and many individual laboratories.Thus, we next investigated whether it is possible to add another
sgRNA to target a sequence that is common among most extra-
chromosomal transgenic animals, to investigate whether such
biological materials could be re-used as parent strains for in-
tegration into a locus of interest. We used sgRNA against the β-
lactamase gene, which is present in all parent strains in the pre-
sent experiments and is likely to be present in most of the existing
extrachromosomal transgenic strains, since the β-lactamase (am-
picillin resistance) gene is contained in general plasmid vectors.
We attempted to integrate extrachromosomal transgenes by using
another strain, tmEx3199, which lacks the dpy-3 sequence in the
extrachromosomal arrays. We injected sgRNAs against both the β-
lactamase and dpy-3 genes as above and obtained 4 integrant
strains from 50 P0 parent animals (8.0%, Table 1, exp. 5). By con-
trast, we could not generate any Is line by injecting tmEx3199 with
sgRNA against only the dpy-3 gene and Cas9 (Table 1, exp. 6,
Supplementary Table 4). We conclude that fragmentation of the
array, in addition to the cleavage of the genome, is important for
efﬁcient integration.
Because the probability of integration with the present method is
high enough to generate integrant lines, we next evaluated how the
integration processes are affected by the conditions used. The me-
chanism of this phenomenon is not currently clear but is likely due to
DNA repair processes such as homologous recombination (HR) and
nonhomologous end-joining (NHEJ) [18] because Cas9 causes double-
strand breaks. If the HR system mainly functions in the mechanism of
integration, integrated strains should be generated more efﬁciently by
tmEx4252, which has a larger number of homologous sequences (Ta-
ble 1, exp. 1, Supplementary Table 4), than by tmEx4277 or tmEx4253
(Table 1, exp. 2, 3, Supplementary Table 4). This was not the case. We
obtained integrant strains at frequencies of 3.6%, 4.4% and 9.3% from
tmEx4252, tmEx4277 and tmEx4253, respectively. These results suggest
that the HR systemmay not play the main role for integration (Fig. 3C,
case 1). This idea is compatible with the fact that Cas9 plasmids are
injected into the germ cells after meiosis which do not have sister
chromosomes. If the NHEJ system mainly functions in the mechanism
of integration, even tmEx3199 can generate the integrant strains. This
was the case. We obtained integrant strains at a frequency of 8.0%
from tmEx3199, which does not have the dpy-3 sequence in the ex-
trachromosomal array (Table 1, exp. 5). This result suggests that the
NHEJ system may play the main role for integration (Fig. 3C, case 2).
To investigate the relationship between the numbers of frag-
mented extrachromosomal array and the efﬁciency of generating
transgenic animals, we compared the results of exp. 1 and exp. 4 in
the Table 1 and Supplementary Table 4. Increasing the cleavage
sites in extrachromosomal arrays induced higher rates of sterile or
larval arrest phenotypes in F1 animals. The same tendency was
observed in exp. 1, exp. 2 and exp. 3 (Table 1, exp. 1–3, Supple-
mentary Table 4). Thus, a higher concentration of DNA fragments
might result in the ligation of chromosomal break points to the
incorrect arms by NHEJ, leading to abortive DNA fragments from
extrachromosomal arrays and causing aneuploidy (Fig. 3C, case 3).
Researcher may wonder which types of extrachromosomal ar-
rays should be used. Extrachromosomal arrays with or without
homologous sequences to insertion sites may be used. However, it
may be easier to use already existing extrachromosomal trans-
genic animals. The Cas9-sgRNA (for β-lactamase) expression vec-
tor is available upon request.
3.3. The expression of reporter genes is proportional to the copy
number of the construct at the same integration locus
To determine the copy number of insertions, we performed
quantitative PCR using puriﬁed genomic DNA as a template. We
designed primer sets located within the promoter of the myo-2 gene
and the dpy-3 gene that were contained in the extrachromosomal
Fig. 2. Expression of myo-2p::Venus in the multi-copy integrated strains (A-D) Venus protein expressed in pharyngeal muscle cells. Scale bar¼100 mm. (400 msec. exposure
time) (E) Relative amounts of themyo-2 promoter and the dpy-3 genome as determined by quantitative PCR. The data were normalized to the ama-1 gene. The copy numbers
are presented as a ratio to the wild-type N2. Bars represent the mean7SE of three independent experiments. (F) Quantiﬁcation of the ﬂuorescence in pharyngeal muscle
cells. The graph represents the intensity of ﬂuorescence of pharyngeal muscle cells (n430 animals per strain). Fluorescence intensity was examined using ImageJ (NIH,
Bethesda, MD). Bars represent the mean7SE. (G) The copy number ratio of themyo-2 promoter to the dpy-3 genome in the 3 parent Ex lines and the 9 Is lines. Bars represent
the mean7SE of three independent experiments. (H) The scatter plot of the number of myo-2 promoter (x-axis) against ﬂuorescence intensity (y-axis) in the 3 Ex lines,
tmEx4252, tmEx4253 and tmEx4277, and the 9 Is lines, tmIs1149, tmIs1150, tmIs1151, tmIs1155, tmIs1156, tmIs1152, tmIs1154, tmIs1158 and tmIs1162.
S. Yoshina et al. / Biochemistry and Biophysics Reports 5 (2016) 70–7674array and in the C. elegans genome. Four Ex lines and 13 integrant
strains were tested and compared to wild-type N2 (Fig. 2E and
Supplementary Fig. 4C). As a result, themyo-2p-to-dpy-3, dpy-30p-to-
ben-1 or vps-45-to-ben-1 ratio in each integrant strain was similar to
each parent Ex strain (Fig. 2G, Supplementary Fig. 4D).
To compare the copy number of the myo-2 promoter sequences
with ﬂuorescence intensity, the integrant strains were photo-
graphed under the same exposure time (Fig. 2A–D and F). Fluor-
escence intensity was highly correlated with the copy number of
the myo-2 promoter (correlation coefﬁcient was 0.924; Fig. 2H).This suggests that the expression of transgenic genes in the in-
tegrant transgenes is nearly proportional to the copy numbers of
the genes among strains with the same integration locus.
3.4. Transgene integration using the CRISPR/Cas9 system, benzimi-
dazole and temperature selection
We previously demonstrated that single/low-copy integrant
strains can be isolated using positive (temperature-sensitive lethal
phenotype rescue) and negative (benomyl-sensitive phenotype
Fig. 3. Schematic diagram of Ex array insertion into the genome by the CRIPSR/Cas9 system. (A) Plasmid structure used in the experiment. (B) Schematic diagram of Ex array.
(C) In case 1, cleaved dpy-3 sequences in C.elegans genome are ligated by homologous recombination (HR) to the intact extrachromosomal (Ex) array. In case 2, a fragmented
Ex array is inserted to the chromosomal break point by nonhomologous end-joining (NHEJ), yielding an ls line. In cases 3, many fragmented Ex arrays are ligated by NHEJ to
chromosomal break points but C.elegans genome are not joined each other, yielding aneuploidy.
S. Yoshina et al. / Biochemistry and Biophysics Reports 5 (2016) 70–76 75rescue) selection [7,8]. We next investigated whether a similar
selection also works using the CRISPR/Cas9 system to isolate
smaller-copy integrations from extrachromosomal arrays. Mutants
of ben-1,which encodes a β-tubulin gene of C. elegans, are resistant
to an anti-tubulin drug benzimidazole [19]. Wild-type C. elegans
worms are severely unhealthy, dumpy, and uncoordinated on
benzimidazole-containing selection media [19]. Thus, ben-1 mu-
tants not carrying the ben-1 gene or carrying an incomplete ben-1
gene in the transgene predominantly grow and reproduce on
benzimidazole-containing media. Temperature selection was
based on rescue of the vps-45 mutant phenotype. The vps-45
mutants are unable to grow and reproduce at 20 °C [15]. vps-45
mutants carrying the vps-45 mini gene grow and reproduce, al-
lowing for easy identiﬁcation of the transformants. To insert the
fragments of extrachromosomal transgenes into the chromo-
somes, ben-1(tm234); vps-45(tm246); tmEx3199 animals were mi-
croinjected with vectors encoding Cas9, a ben-1-speciﬁc sgRNA
and an injection marker. The progeny of microinjected animals
were cultured on benzimidazole-containing NGM plates, and the
animals that grew and reproduced on benzimidazole-containing
media were cultured on NGM plates at 20 °C. We performed PCR
selection to amplify the GFP sequence, using animals that survivedthis selection as templates (Supplementary Fig. 2A). As a result,
2 integrant strains, tmIs1159 and tmIs1160, were isolated from 54
injected worms (Supplementary Figs. 2B, 3A and B). This method
produced a much higher frequency (3.7%) than the previous UV/
TMP protocol (0.033%) [7]. We conﬁrmed that the transgenes were
integrated at the ben-1 locus in tmIs1159 and tmIs1160 by PCR and
sequencing (Supplementary Fig. 1).
To determine the copy number of insertions, we performed
quantitative PCR using primer sets for the dpy-30p, vps-45 and
ben-1 genes using puriﬁed genomic DNA as templates. tmIs1159
and tmIs1160 were tested for the copy number of these sequences
and compared to wild-type N2 (Supplementary Fig. 3C and D).
tmIs1159 carried approximately 35, 22 and 22 copies of the dpy-
30p, vps-45 and ben-1 genes, respectively. tmIs1160 carried ap-
proximately 27, 16 and 10 copies of the dpy-30p, vps-45 and ben-1
genes, respectively (Supplementary Fig. 3C). This result indicates
that the CRISPR/cas9 system is also useful for positive/negative
selection via benzimidazole and temperature selection. tmIs1159
and tmIs1160 contained a slightly larger number of copies than the
previously isolated single/low-copy transgenic strains [7,8]. Be-
cause the integrant strains isolated in the present study were re-
sistant to benzimidazole, it is conceivable that the residual ben-1
S. Yoshina et al. / Biochemistry and Biophysics Reports 5 (2016) 70–7676genes in the integrant strains were disrupted through cleavage by
the ben-1 sgRNA and Cas9. Thus, the negative selection by benzi-
midazole was not as strong as before. We expected that the ex-
perimental conditions including the combination of sgRNA against
the β-lactamase sequence for extrachromosomes and the dpy-3
sequence for the chromosomal integration site could yield in-
tegrants of single/low-copy, as before. GFP Fluorescence was not
observed in the germ cells (data not shown), suggesting inter-
mediate-copy number transgenes might be silenced [20].
In conclusion, we developed an efﬁcient method for the locus-
speciﬁc integration of extrachromosomal arrays into chromo-
somes using the CRISPR/Cas9 system, while extrachromosomal
arrays are integrated into random loci by previous methods. To
generate integrant strains efﬁciently, it is important to cut extra-
chromosomal arrays in a moderate number of fragments. Although
it has been a concern that expression levels are not reproducible
depending on the integration site, researchers can now easily
compare the expression and functions of various constructs at
deﬁned integration loci. Moreover, when using multiple mutants
and integrant transgenics, it is apparently beneﬁcial to use trans-
genic strains with convenient integration sites.Conﬂict of interest
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